| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 17, 2007
From the Veterans Affairs Medical Center, Cardiology Department (P. Kokkinos, J.P.K., A.P., P.N., A.M., P. Karasik, M.G., V.P.), and Georgetown University School of Medicine (P. Kokkinos, S.S.), Washington, DC, and Veterans Affairs Palo Alto Health Care System, Cardiology Division, and Stanford University, Stanford, Calif (J.M.). * To whom correspondence should be addressed. E-mail: peter.kokkinos{at}med.va.gov.
Background—Exercise capacity is inversely related to mortality risk in healthy individuals and those with cardiovascular diseases. This evidence is based largely on white populations, with little information available for blacks. Methods and Results—We assessed the association between exercise capacity and mortality in black (n=6749; age, 58±11 years) and white (n=8911; age, 60±11 years) male veterans with and without cardiovascular disease who successfully completed a treadmill exercise test at the Veterans Affairs Medical Centers in Washington, DC, and Palo Alto, Calif. Fitness categories were based on peak metabolic equivalents (METs) achieved. Subjects were followed up for all-cause mortality for 7.5±5.3 years. Among clinical and exercise test variables, exercise capacity was the strongest predictor of risk for mortality. The adjusted risk was reduced by 13% for every 1-MET increase in exercise capacity (hazard ratio, 0.87; 95% confidence interval, 0.86 to 0.88; P<0.001). Compared with those who achieved <5 METs, the mortality risk was Conclusions—Exercise capacity is a strong predictor of all-cause mortality in blacks and whites. The relationship was inverse and graded, with a similar impact on mortality outcomes for both blacks and whites.
Accepted on November 8, 2007
Exercise Capacity and Mortality in Black and White Men
Peter Kokkinos PhD*,
50% lower for those with an exercise capacity of 7.1 to 10 METs (hazard ratio, 0.51; 95% confidence interval, 0.47 to 0.56; P<0.001) and 70% lower for those achieving >10 METs (hazard ratio, 0.31; 95% confidence interval, 0.26 to 0.36; P<0.001). The findings were similar for those with and without cardiovascular disease and for both races.
Find additional patient-related information at:
Related Article:
This article has been cited by other articles:
![]() |
J.-Y. Park, P.-y. Wang, T. Matsumoto, H. J. Sung, W. Ma, J. W. Choi, S. A. Anderson, S. C. Leary, R. S. Balaban, J.-G. Kang, et al. p53 Improves Aerobic Exercise Capacity and Augments Skeletal Muscle Mitochondrial DNA Content Circ. Res., September 25, 2009; 105(7): 705 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Leon and U. G. Bronas Pathophysiology of Coronary Heart Disease and Biological Mechanisms for the Cardioprotective Effects of Regular Aerobic Exercise American Journal of Lifestyle Medicine, September 1, 2009; 3(5): 379 - 385. [Abstract] [PDF] |
||||
![]() |
A. S. Leon Biological Mechanisms for the Cardioprotective Effects of Aerobic Exercise American Journal of Lifestyle Medicine, July 1, 2009; 3(1_suppl): 32S - 34S. [Abstract] [PDF] |
||||
![]() |
P. Kokkinos, J. Myers, E. Nylen, D. B. Panagiotakos, A. Manolis, A. Pittaras, M. R. Blackman, R. Jacob-Issac, C. Faselis, J. Abella, et al. Exercise Capacity and All-Cause Mortality in African American and Caucasian Men With Type 2 Diabetes Diabetes Care, April 1, 2009; 32(4): 623 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Stamatakis, M Hamer, and P Primatesta Cardiovascular medication, physical activity and mortality: cross-sectional population study with ongoing mortality follow-up Heart, March 15, 2009; 95(6): 448 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kokkinos, A. Manolis, A. Pittaras, M. Doumas, A. Giannelou, D. B. Panagiotakos, C. Faselis, P. Narayan, S. Singh, and J. Myers Exercise Capacity and Mortality in Hypertensive Men With and Without Additional Risk Factors Hypertension, March 1, 2009; 53(3): 494 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kokkinos Physical Activity and Cardiovascular Disease Prevention: Current Recommendations Angiology, August 1, 2008; 59(2_suppl): 26S - 29S. [Abstract] [PDF] |
||||
![]() |
E. Roelker Screening for Coronary Artery Disease in Patients With Diabetes Diabetes Spectr, July 1, 2008; 21(3): 166 - 171. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |